|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
See Header: Exposure of other implanted mesh into organ or tissue
ICD-10 (CM) Code and Descriptor
|
T83.728A |
Exposure of other implanted mesh into organ or tissue, initial encounter
|
T83728A utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 9 |
ICD10
Position 12 |
| 29.02%
|
39.51%
|
15.38%
|
8.04%
|
3.50%
|
2.45%
|
1.40%
|
0.35%
|
0.35%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T83.728A*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2704
|
INJ, PROPOFOL, 10 MG |
47
|
964
|
|
J3010
|
FENTANYL CITRATE INJECTION |
46
|
71
|
|
J2405
|
ONDANSETRON HCL INJECTION |
37
|
154
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
33
|
105
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
27
|
210
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
27
|
57
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
24
|
46
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
22
|
22
|
|
11042
|
DBRDMT SUBQ TIS 1ST 20SQCM/< |
20
|
20
|
|
J7120
|
RINGERS LACTATE INFUSION |
18
|
24
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
17
|
67
|
|
J1170
|
HYDROMORPHONE INJECTION |
16
|
18
|
|
J2001
|
LIDOCAINE INJECTION |
15
|
100
|
|
J0131
|
INJ, ACETAMINOPHEN (NOS) |
14
|
1,301
|
|
80048
|
METABOLIC PANEL TOTAL CA |
13
|
13
|
|
11045
|
DBRDMT SUBQ TISS EACH ADDL |
12
|
60
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
11
|
19
|
|
J0330
|
SUCCINYCHOLINE CHLORIDE INJ |
11
|
73
|
|
85027
|
COMPLETE CBC AUTOMATED |
10
|
10
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
10
|
10
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T83.728A related to the following DRG Codes:
698-700
|
